IPP Bureau
Lupin Digital Health partners with Medicover Hospitals for post discharge cardiac care
By IPP Bureau - December 22, 2024
Lonza expands capsule manufacturing capacity in India and China
By IPP Bureau - December 21, 2024
New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari and Suzhou
ANVISA inspection received from Brazil Health Regulatory Agency at Wanbury Tanuku facility
By IPP Bureau - December 21, 2024
The company will receive GMP compliance certificate which will further help to accelerate the business growth across the globe
USFDA approves Encorafenib plus Cetuximab and Chemo in BRAF V600E-positive mCRC
By IPP Bureau - December 21, 2024
Accelerated approval is based on 61% overall response rate compared to 40% in control arm in the
Merck closes license agreement for LM-299
By IPP Bureau - December 21, 2024
Merck will record a pre-tax charge relating to the upfront payment of $588 million
India is the fourth largest medical devices market in Asia: Anupriya Patel
By IPP Bureau - December 20, 2024
The segment has immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities
Zydus receives final approval from USFDA for Lidocaine and Prilocaine Cream USP
By IPP Bureau - December 20, 2024
Lidocaine and Prilocaine cream had annual sales of US $22.05 million in the United States (IQVIA MAT October 2024)
Kenvue India presents report on ‘The Hydration Gap for Non-Diarrheal Illnesses’
By IPP Bureau - December 20, 2024
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat
By IPP Bureau - December 20, 2024
This facility marks a significant milestone in transforming the global food industr
Cipla launches India's first inhalable insulin ‘Afrezza’
By IPP Bureau - December 19, 2024
Afrezza, developed by MannKind Corporation in the USA, offers a needle-free, rapid-acting insulin option for diabetes management
Caplin Steriles gets USFDA approval for Difluprednate Ophthalmic emulsion
By IPP Bureau - December 17, 2024
Difluprednate Ophthalmic Emulsion, 0.05% is a topical corticosteroid that is indicated in the treatment of inflammation and pain associated with ocular surgery
Zaynich enables US cancer patient undergo successful liver transplant and resume chemotherapy
By IPP Bureau - December 17, 2024
In the US, the compassionate use approvals are provided by FDA in the form of individual patient-specific expanded-access IND
Glenmark USA launches Lacosamide Oral Solution, 10 mg/mL
By IPP Bureau - December 17, 2024
According to IQVIATM sales data for the 12-month period ending October 2024, the Vimpat Oral Solution, 10 mg/mL market achieved annual sales of approximately $57.0 million
Merck to discontinue KeyVibe and Keyform clinical trials
By IPP Bureau - December 17, 2024
Merck has also decided to end the favezelimab clinical development program
SPARC signs LoI with UCSF and Tiller Therapeutics for pre-clinical oncology asset and associated IP
By IPP Bureau - December 17, 2024
SPARC to receive 55% equity in Tiller Therapeutics
